152 related articles for article (PubMed ID: 33177111)
1. Sialylation of CD55 by ST3GAL1 Facilitates Immune Evasion in Cancer.
Lin WD; Fan TC; Hung JT; Yeo HL; Wang SH; Kuo CW; Khoo KH; Pai LM; Yu J; Yu AL
Cancer Immunol Res; 2021 Jan; 9(1):113-122. PubMed ID: 33177111
[TBL] [Abstract][Full Text] [Related]
2. Sialylation of vasorin by ST3Gal1 facilitates TGF-β1-mediated tumor angiogenesis and progression.
Yeo HL; Fan TC; Lin RJ; Yu JC; Liao GS; Chen ES; Ho MY; Lin WD; Chen K; Chen CH; Hung JT; Wu JC; Chang NC; Chang MD; Yu J; Yu AL
Int J Cancer; 2019 Apr; 144(8):1996-2007. PubMed ID: 30252131
[TBL] [Abstract][Full Text] [Related]
3. Human B Cell Differentiation Is Characterized by Progressive Remodeling of O-Linked Glycans.
Giovannone N; Antonopoulos A; Liang J; Geddes Sweeney J; Kudelka MR; King SL; Lee GS; Cummings RD; Dell A; Barthel SR; Widlund HR; Haslam SM; Dimitroff CJ
Front Immunol; 2018; 9():2857. PubMed ID: 30619255
[TBL] [Abstract][Full Text] [Related]
4. Reciprocal feedback regulation of ST3GAL1 and GFRA1 signaling in breast cancer cells.
Fan TC; Yeo HL; Hsu HM; Yu JC; Ho MY; Lin WD; Chang NC; Yu J; Yu AL
Cancer Lett; 2018 Oct; 434():184-195. PubMed ID: 30040982
[TBL] [Abstract][Full Text] [Related]
5. Sialyltransferase ST3GAL1 promotes cell migration, invasion, and TGF-β1-induced EMT and confers paclitaxel resistance in ovarian cancer.
Wu X; Zhao J; Ruan Y; Sun L; Xu C; Jiang H
Cell Death Dis; 2018 Oct; 9(11):1102. PubMed ID: 30375371
[TBL] [Abstract][Full Text] [Related]
6. Overlapping and unique substrate specificities of ST3GAL1 and 2 during hematopoietic and megakaryocytic differentiation.
Zhang N; Lin S; Cui W; Newman PJ
Blood Adv; 2022 Jul; 6(13):3945-3955. PubMed ID: 35507766
[TBL] [Abstract][Full Text] [Related]
7. Analyses of chicken sialyltransferases related to O-glycosylation.
Kidani S; Kaneoka H; Okuzaki Y; Asai S; Kojima Y; Nishijima K; Iijima S
J Biosci Bioeng; 2016 Oct; 122(4):379-84. PubMed ID: 27150510
[TBL] [Abstract][Full Text] [Related]
8. ST3GAL1-Associated Transcriptomic Program in Glioblastoma Tumor Growth, Invasion, and Prognosis.
Chong YK; Sandanaraj E; Koh LW; Thangaveloo M; Tan MS; Koh GR; Toh TB; Lim GG; Holbrook JD; Kon OL; Nadarajah M; Ng I; Ng WH; Tan NS; Lim KL; Tang C; Ang BT
J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26547933
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of membrane complement inhibitor expression (CD46, CD55, CD59) by siRNA sensitizes tumor cells to complement attack in vitro.
Geis N; Zell S; Rutz R; Li W; Giese T; Mamidi S; Schultz S; Kirschfink M
Curr Cancer Drug Targets; 2010 Dec; 10(8):922-31. PubMed ID: 20879979
[TBL] [Abstract][Full Text] [Related]
10. Oxidative damage and response to Bacillus Calmette-Guérin in bladder cancer cells expressing sialyltransferase ST3GAL1.
Severino PF; Silva M; Carrascal M; Malagolini N; Chiricolo M; Venturi G; Barbaro Forleo R; Astolfi A; Catera M; Videira PA; Dall'Olio F
BMC Cancer; 2018 Feb; 18(1):198. PubMed ID: 29454317
[TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase-2 enzyme induces the expression of the α-2,3-sialyltransferase-3 (ST3Gal-I) in breast cancer.
Sproviero D; Julien S; Burford B; Taylor-Papadimitriou J; Burchell JM
J Biol Chem; 2012 Dec; 287(53):44490-7. PubMed ID: 23275522
[TBL] [Abstract][Full Text] [Related]
12. Altered O-linked glycosylation in benign and malignant meningiomas.
Talabnin C; Trasaktaweesakul T; Jaturutthaweechot P; Asavaritikrai P; Kongnawakun D; Silsirivanit A; Araki N; Talabnin K
PeerJ; 2024; 12():e16785. PubMed ID: 38274327
[TBL] [Abstract][Full Text] [Related]
13. Restoration of compact Golgi morphology in advanced prostate cancer enhances susceptibility to galectin-1-induced apoptosis by modifying mucin O-glycan synthesis.
Petrosyan A; Holzapfel MS; Muirhead DE; Cheng PW
Mol Cancer Res; 2014 Dec; 12(12):1704-16. PubMed ID: 25086069
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the specificity of sialyltransferases toward mucin core 2, globo, and related structures. identification of the sialylation sequence and the effects of sulfate, fucose, methyl, and fluoro substituents of the carbohydrate chain in the biosynthesis of selectin and siglec ligands, and novel sialylation by cloned alpha2,3(O)sialyltransferase.
Chandrasekaran EV; Xue J; Xia J; Chawda R; Piskorz C; Locke RD; Neelamegham S; Matta KL
Biochemistry; 2005 Nov; 44(47):15619-35. PubMed ID: 16300412
[TBL] [Abstract][Full Text] [Related]
15. ST3GAL1 is a target of the SOX2-GLI1 transcriptional complex and promotes melanoma metastasis through AXL.
Pietrobono S; Anichini G; Sala C; Manetti F; Almada LL; Pepe S; Carr RM; Paradise BD; Sarkaria JN; Davila JI; Tofani L; Battisti I; Arrigoni G; Ying L; Zhang C; Li H; Meves A; Fernandez-Zapico ME; Stecca B
Nat Commun; 2020 Nov; 11(1):5865. PubMed ID: 33203881
[TBL] [Abstract][Full Text] [Related]
16. An alpha2,3 sialyltransferase (ST3Gal I) is elevated in primary breast carcinomas.
Burchell J; Poulsom R; Hanby A; Whitehouse C; Cooper L; Clausen H; Miles D; Taylor-Papadimitriou J
Glycobiology; 1999 Dec; 9(12):1307-11. PubMed ID: 10561455
[TBL] [Abstract][Full Text] [Related]
17. Evidence for an O-glycan sialylation system in brain. Characterization of a beta-galactoside alpha 2,3-sialyltransferase from rat brain regulating the expression of an alpha-N-acetylgalactosaminide alpha 2,6-sialyltransferase activity.
Baubichon-Cortay H; Broquet P; George P; Louisot P
Eur J Biochem; 1989 Jun; 182(2):257-65. PubMed ID: 2472271
[TBL] [Abstract][Full Text] [Related]
18. Over-expression of ST3Gal-I promotes mammary tumorigenesis.
Picco G; Julien S; Brockhausen I; Beatson R; Antonopoulos A; Haslam S; Mandel U; Dell A; Pinder S; Taylor-Papadimitriou J; Burchell J
Glycobiology; 2010 Oct; 20(10):1241-50. PubMed ID: 20534593
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the coordinated role of ST3GAL3, ST3GAL4 and ST3GAL6 on the α2,3 sialylation linkage of mammalian glycoproteins.
Chung CY; Yin B; Wang Q; Chuang KY; Chu JH; Betenbaugh MJ
Biochem Biophys Res Commun; 2015 Jul; 463(3):211-5. PubMed ID: 25998389
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of membrane complement inhibitors CD55 and CD59 by siRNA sensitises uterine serous carcinoma overexpressing Her2/neu to complement and antibody-dependent cell cytotoxicity in vitro: implications for trastuzumab-based immunotherapy.
Bellone S; Roque D; Cocco E; Gasparrini S; Bortolomai I; Buza N; Abu-Khalaf M; Silasi DA; Ratner E; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD
Br J Cancer; 2012 Apr; 106(9):1543-50. PubMed ID: 22531721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
